article thumbnail

Biomarkers in COPD

HCPLive

Igor Barjaktarevic, MD, PhD, provides insights on the evolving role of biomarkers in COPD, highlighting the role of eosinophils on informing treatment decisions.

article thumbnail

Pavel Strnad, MD: Noninvasive Testing, Candidate Biomarkers in AATD-Associated Liver Disease

HCPLive

Strnad explains key findings from research presented at the EASL Congress regarding noninvasive testing and biomarkers in AATD-LD based on phase 2 fazirsiran clinical trials.

article thumbnail

Urinary Inflammatory Biomarkers Show Prognostic Value for IgA Nephropathy

HCPLive

Urinary cytokines GDF-15, IL-6, and EGF significantly strengthened the predictability of IgAN prognosis and may be viable biomarker candidates for disease progression.

article thumbnail

Heart transplantation and biomarkers: a review about their usefulness in clinical practice

Frontiers in Cardiovascular Medicine

As a result, numerous biomarkers have been investigated in an effort to identify and prevent certain diseases sooner. These biomarkers are typically linked to complications from HTX. We also highlight the relationships between each biomarker and one or more problems, as well as their applicability in routine clinical practice.

article thumbnail

Two common biomarkers can predict heart risk in asymptomatic childhood cancer survivors

Medical Xpress - Cardiology

Jude LIFE) have revealed that two common biomarkers of cardiac function and damage could better predict cardiomyopathy within five years than routine clinical evaluations in high-risk, asymptomatic childhood cancer survivors. Jude lifetime cohort study (St.

article thumbnail

RCE Technologies, Inc. Announces First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring

DAIC

This is an innovative platform for measuring biomarkers,” stated Dr. Karlsberg. This study highlights the value of digital biomarkers that may enable instantaneous feedback for care providers in assessing the patient. milla1cf Mon, 04/22/2024 - 15:05 April 22, 2024 — At the annual American College of Cardiology conference ( ACC.24

article thumbnail

Semaglutide Reduced Inflammatory Biomarkers in HIV Patients With Lipohypertrophy

Med Page Today

(MedPage Today) -- DENVER -- People with HIV who received semaglutide (Ozempic, Wegovy) had reduced levels of several inflammatory biomarkers associated with cardiovascular disease, a randomized controlled trial showed. After 32 weeks, interleukin.